RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl Fumarate

Summary

This is a Phase IV, prospective, open-label, multi-center trial to assess the treatment satisfaction in patients with relapsing forms of Multiple Sclerosis (MS) who are currently being treated with, but are considering discontinuing treatment with Tecfidera™.

Timeline

Start

2014-06

Primary completion

2015-04

Completion

2015-04

Drugs

Indications